Esophagogastric junction outflow obstruction was diagnosed in 16 (34.8%) patients, and ineffective esophageal motility was diagnosed in 8 (17.4%) patients. None of the subjects reported symptoms ...
“Patients diagnosed with advanced gastric and esophageal cancers confront median survival times measured in months, not years—highlighting the urgent need for more effective treatment options ...
Esophageal cancer is one of the most deadly cancers — so why doesn’t the healthcare industry have better tools to prevent the disease? Lucid Diagnostics is on a mission to solve that problem.